Results 71 to 80 of about 5,040 (223)

Expressão fenotípica da miocardiopatia hipertrófica e realce tardio na ressonância magnética cardíaca [PDF]

open access: yes, 2014
INTRODUCTION AND AIM: The prognostic value of late gadolinium enhancement (LGE) for risk stratification of hypertrophic cardiomyopathy (HCM) patients is the subject of disagreement.
Almeida, I   +8 more
core   +1 more source

Bimanual examination for septal myectomy for hypertrophic cardiomyopathy [PDF]

open access: yesInteractive CardioVascular and Thoracic Surgery, 2014
Left ventricular septal myectomy is the therapeutic 'gold standard' for patients with obstructive hypertrophic cardiomyopathy whose symptoms are refractory to medical therapy. We describe our initial clinical experience with a new surgical technique for septal myectomy utilizing the 'bimanual examination' in order to more reliably complete extended ...
Shinichi, Fukuhara   +3 more
openaire   +2 more sources

Incremental Value of NT‐proBNP Over HCM‐AF Score in Risk Stratification for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

open access: yesClinical Cardiology, Volume 49, Issue 3, March 2026.
In Asian patients with hypertrophic cardiomyopathy, integrating NT‐proBNP with the clinical HCM‐AF score provides significant incremental prognostic value. This combined multiparametric assessment enhances the predictive accuracy for new‐onset atrial fibrillation, enabling more precise risk stratification and targeted clinical management.
Yi‐Peng Gao   +10 more
wiley   +1 more source

From 100 to 0

open access: yesJACC: Case Reports, 2020
Septal reduction techniques can reduce morbidity and mortality in patients with hypertrophic cardiomyopathy. In a patient with hypertrophic cardiomyopathy who was a poor candidate for surgical myectomy and alcohol septal ablation, endocardial ...
Graham Peigh, MD   +4 more
doaj   +1 more source

Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free wall): a follow-up study using CMR tissue tagging and 3D strain analysis [PDF]

open access: yes, 2006
Aims: Alcohol septal ablation (ASA) has been successful in the treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study is to evaluate the effects of ethanol-induced myocardial infarcts on regional myocardial ...
Beek, A.M.   +9 more
core   +2 more sources

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long‐Term Follow‐Up of Deformations and Hemodynamics

open access: yesJournal of Magnetic Resonance Imaging, Volume 63, Issue 3, Page 859-871, March 2026.
ABSTRACT Background A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA). Purpose To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics ...
Kenichiro Suwa   +5 more
wiley   +1 more source

Myectomy septal hypertrophic cardiomyopathy with obstruction in the outflow tract of the left ventricle

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2015
Resumen La miocardiopatía hipertrófica tiene como complicaciones la insuficiencia cardíaca diastólica, arritmias, síncope y la muerte súbita. La miectomía septal es la indicación primera para el tratamiento de dicha entidad con obstrucción del tracto de
Amaury Flores Sánchez   +4 more
doaj  

MODIFIED TECHNIQUE OF MANAGEMENT FOR DISCRETE AND DIFFUSE SUBAORTIC STENOSIS

open access: yesНеотложная медицинская помощь, 2017
We report a new original method of management for subaortic stenosis. When performing myectomy from the transaortic access of Morrow, the significant problem is poor visualization of the interventricular septum.
M. A. Martakov   +3 more
doaj   +1 more source

Myectomy with and without Mitral Subvalvular Repair in Patients with Hypertrophic Obstructive Cardiomyopathy with Grade 3 to 4+ Mitral Regurgitation without Intrinsic Mitral Valve Disease: A Retrospective Observational Study

open access: yesReviews in Cardiovascular Medicine, 2022
Background: Hypertrophic obstructive cardiomyopathy (HOCM) with severe mitral regurgitation (MR) remains controversial for the choice of the concomitant mitral valve (MV) management versus septal myectomy alone.
Fangyu Liu   +6 more
doaj   +1 more source

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 5, Page 1122-1139, March 2026.
Abstract Background and Purpose Mavacamten (MAVA) is a novel small molecule inhibitor of cardiac myosin, mitigating cardiomyocyte hypercontractility in patients with hypertrophic obstructive cardiomyopathy (HOCM). Despite its recent approval for clinical use, the transcriptional and functional impacts of MAVA remain not well understood.
Elisa Kiselev   +36 more
wiley   +1 more source

Home - About - Disclaimer - Privacy